Study S002132

The Effect of Semaglutide Compared to Metformin in Obese Women With Polycystic Ovary Syndrome (PCOS): a Randomised Controlled Study (Semaglutide-PCOS Trial).

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05646199
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 60
Start: 2025-03-01
Primary completion: 2025-09-30
Lead sponsor: University of Hull
Conditions: Polycystic Ovary Syndrome
Interventions: DRUG:Metformin; DRUG:Semaglutide Injectable Product
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Weight loss (kg) [28 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.